
Dung Anh Le
Examiner (ID: 16582, Phone: (571)272-1784 , Office: P/2819 )
| Most Active Art Unit | 2818 |
| Art Unit(s) | 2819, 2818 |
| Total Applications | 2716 |
| Issued Applications | 2558 |
| Pending Applications | 17 |
| Abandoned Applications | 155 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19246690
[patent_doc_number] => 20240197674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => NOVEL USE OF 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 18/552988
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552988 | NOVEL USE OF 3-(4-(BENZYLOXY)PHENYL)HEX-4-INOIC ACID DERIVATIVE | Mar 9, 2022 | Pending |
Array
(
[id] => 19018834
[patent_doc_number] => 20240075005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => Treatment of Overactive Bladder with Oxybutynin Applied By Means of a Vaginal Ring
[patent_app_type] => utility
[patent_app_number] => 18/274646
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/274646 | Treatment of Overactive Bladder with Oxybutynin Applied By Means of a Vaginal Ring | Feb 27, 2022 | Pending |
Array
(
[id] => 17865261
[patent_doc_number] => 20220287996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING EDEMA REFRACTORY TO ORAL DIURETICS
[patent_app_type] => utility
[patent_app_number] => 17/680591
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17680591
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/680591 | Methods and compositions for treating edema refractory to oral diuretics | Feb 24, 2022 | Issued |
Array
(
[id] => 17835668
[patent_doc_number] => 20220272973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 17/678579
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/678579 | Preservatives for Cosmetic, Toiletry and Pharmaceutical Compositions | Feb 22, 2022 | Abandoned |
Array
(
[id] => 17790403
[patent_doc_number] => 20220249494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
[patent_app_type] => utility
[patent_app_number] => 17/676017
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676017
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676017 | USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17655320
[patent_doc_number] => 20220175785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK)
[patent_app_type] => utility
[patent_app_number] => 17/676032
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676032
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/676032 | USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | Feb 17, 2022 | Abandoned |
Array
(
[id] => 17828400
[patent_doc_number] => 20220265704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => TREATMENT OF AUTISM AND AUTISM SPECTRUM DISORDERS WITH BIOTIN COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/672592
[patent_app_country] => US
[patent_app_date] => 2022-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672592 | TREATMENT OF AUTISM AND AUTISM SPECTRUM DISORDERS WITH BIOTIN COMPOSITIONS | Feb 14, 2022 | Abandoned |
Array
(
[id] => 17827571
[patent_doc_number] => 20220264875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => MULTIFUNCTIONAL NATURAL PROTECTANT SYSTEMS WITH HYDROXYACETOPHENONE
[patent_app_type] => utility
[patent_app_number] => 17/650417
[patent_app_country] => US
[patent_app_date] => 2022-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/650417 | Multifunctional natural protectant systems with hydroxyacetophenone | Feb 8, 2022 | Issued |
Array
(
[id] => 17895294
[patent_doc_number] => 20220304956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHOD FOR THE TREATMENT OF COVID-19 INFECTIONS WITH PALMITOYLETHANOLAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/665894
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665894
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665894 | Method for the treatment of COVID-19 infections with palmitoylethanolamide | Feb 6, 2022 | Issued |
Array
(
[id] => 17609695
[patent_doc_number] => 20220151974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => METHOD AND COMPOUND FOR THE TREATMENT OF COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/665806
[patent_app_country] => US
[patent_app_date] => 2022-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665806 | METHOD AND COMPOUND FOR THE TREATMENT OF COVID-19 | Feb 6, 2022 | Abandoned |
Array
(
[id] => 17609737
[patent_doc_number] => 20220152016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Compositions And Kits Useful For Treatment Of Respiratory Illness
[patent_app_type] => utility
[patent_app_number] => 17/590796
[patent_app_country] => US
[patent_app_date] => 2022-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17590796
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/590796 | Compositions and kits useful for treatment of respiratory illness | Jan 31, 2022 | Issued |
Array
(
[id] => 17609732
[patent_doc_number] => 20220152011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/589281
[patent_app_country] => US
[patent_app_date] => 2022-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/589281 | Uses of piperidinyl-indole derivatives | Jan 30, 2022 | Issued |
Array
(
[id] => 19447288
[patent_doc_number] => 20240307418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => TREATMENT OF SLEEP APNEA WITH CBD
[patent_app_type] => utility
[patent_app_number] => 18/263092
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263092 | TREATMENT OF SLEEP APNEA WITH CBD | Jan 27, 2022 | Pending |
Array
(
[id] => 18522853
[patent_doc_number] => 20230233502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => COCRYSTAL COMPRISING CAMOSTAT AND NICLOSAMIDE, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/007153
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007153
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/007153 | Cocrystal comprising camostat and niclosamide, pharmaceutical composition comprising same and preparation method therefor | Jan 27, 2022 | Issued |
Array
(
[id] => 19049246
[patent_doc_number] => 20240091215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/272326
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18272326
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/272326 | TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE TREATMENT OF MYELODYSPLASTIC SYNDROME | Jan 16, 2022 | Pending |
Array
(
[id] => 17561598
[patent_doc_number] => 20220125747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => APPLICATION OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/570584
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570584 | APPLICATION OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM EXTRACT | Jan 6, 2022 | Abandoned |
Array
(
[id] => 18018940
[patent_doc_number] => 20220370439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE
[patent_app_type] => utility
[patent_app_number] => 17/570998
[patent_app_country] => US
[patent_app_date] => 2022-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/570998 | THERAPEUTIC USES OF 1-[2-(2,4-DIMETHYL-PHENYLSULFANYL)PHENYL]PIPERAZINE | Jan 6, 2022 | Abandoned |
Array
(
[id] => 17799011
[patent_doc_number] => 11413277
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Non-aqueous liquid nimodipine compositions
[patent_app_type] => utility
[patent_app_number] => 17/558924
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558924
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558924 | Non-aqueous liquid nimodipine compositions | Dec 21, 2021 | Issued |
Array
(
[id] => 17532316
[patent_doc_number] => 20220110925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => Non-Aqueous Liquid Nimodipine Compositions
[patent_app_type] => utility
[patent_app_number] => 17/558919
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17558919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/558919 | Non-Aqueous Liquid Nimodipine Compositions | Dec 21, 2021 | Abandoned |
Array
(
[id] => 17655262
[patent_doc_number] => 20220175727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Anti-Inflammatory and Mydriatic Intracameral Solutions for Inhibition of Postoperative Ocular Inflammatory Conditions
[patent_app_type] => utility
[patent_app_number] => 17/554842
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554842
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554842 | Anti-inflammatory and mydriatic intracameral solutions for inhibition of postoperative ocular inflammatory conditions | Dec 16, 2021 | Issued |